(Q51582724)

7 April 2018

title

Steady-state plasma concentrations of midazolam in critically ill infants and children. (English)

1 reference

7 April 2018

1 reference

J Hughes

1

1 reference

7 April 2018

A M Gill

2

1 reference

7 April 2018

H Mulhearn

3

1 reference

7 April 2018

E Powell

4

1 reference

7 April 2018

I Choonara

5

1 reference

7 April 2018

language of work or name

English

0 references

publication date

1 January 1996

1 reference

7 April 2018

Annals of Pharmacotherapy

published in

1 reference

7 April 2018

volume

30

1 reference

7 April 2018

page(s)

27-30

1 reference

7 April 2018

issue

1

1 reference

7 April 2018

Sedation of children requiring artificial ventilation using an infusion of midazolam.

cites work

1 reference

https://api.crossref.org/works/10.1177%2F106002809603000104

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603000104

A pharmacokinetic study of midazolam in paediatric patients undergoing cardiac surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603000104

Pharmacokinetics of midazolam in critically ill neonates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603000104

Pharmacokinetics of midazolam during continuous infusion in critically ill neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603000104

A potentially hazardous interaction between erythromycin and midazolam.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603000104

Morphine metabolism in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603000104

Morphine metabolism in neonates and infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603000104

The pharmacokinetics of midazolam in paediatric patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603000104

Pharmacokinetics of flumazenil and midazolam.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603000104

A prospective study of the adverse effects of midazolam on withdrawal in critically ill children

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603000104

Clinical pharmacokinetics of midazolam in intensive care patients, a wide interpatient variability?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603000104

Infusion of midazolam in paediatric patients after cardiac surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603000104

Regioselective biotransformation of midazolam by members of the human cytochrome P450 3A (CYP3A) subfamily.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603000104

Profound reduction in morphine clearance and liver blood flow in shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603000104

Altered phenytoin clearance with febrile illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603000104

Clinical experience with continuous intravenous sedation using midazolam and fentanyl in the paediatric intensive care unit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603000104

Pharmacokinetics of midazolam in children: comparative study of intranasal and intravenous administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603000104

Pharmacokinetic and pharmacodynamic study of midazolam in children during esophagogastroduodenoscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603000104

10.1177/106002809603000104

21 January 2018

Identifiers

DOI

1 reference

7 April 2018

PubMed ID

8773161

1 reference

7 April 2018